Agios Pharmaceuticals, Inc. (AGIO)
28.16
+0.16
(+0.57%)
USD |
NASDAQ |
May 01, 16:00
28.18
+0.02
(+0.05%)
After-Hours: 20:00
Agios Pharmaceuticals EPS Diluted (Quarterly) : -1.686 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Eli Lilly & Co. | 8.255 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -99.11M |
| Revenue (Quarterly) | 20.75M |
| Total Expenses (Quarterly) | 119.86M |
| Enterprise Value | 973.43M |
| Gross Profit Margin (Quarterly) | 87.07% |
| Profit Margin (Quarterly) | -477.7% |
| Earnings Yield | -25.75% |
| Normalized Earnings Yield | -25.75 |